Warning over menopause drug and ‘rare but serious’ liver injury risk
The US medicines watchdog has recommended more frequent liver testing for patients taking the new non-hormonal menopause drug fezolinetant after an isolated but serious liver…
The US medicines watchdog has recommended more frequent liver testing for patients taking the new non-hormonal menopause drug fezolinetant after an isolated but serious liver…
Middle-aged women with eating disorders could slip into menopause without realising it, drastically increasing their fracture risk, a leading endocrinologist warns. Eating disorders such as…
Circulating testosterone within the high-normal range is associated with a higher risk of incident AF in older men, according to Australian researchers. Regardless of whether…
The PBAC has rejected a twice-daily medication for Cushing’s syndrome for the second time because of its cost, despite acknowledging it was an effective therapy…
GPs can now prescribe the non-hormonal menopause drug fezolinetant to women with moderate to severe vasomotor symptoms, following TGA approval of the first-of-its-kind treatment. The…
Women initiated on systemic hormone therapy before or during menopause are at greater risk of depression than non-users, a large cohort study shows. In contrast,…
Gender-affirming hormone therapy associated with increased serum creatinine in transgender men, but not transgender women.
When she was struck off in 2020, she said Mr Dank had threatened her.
While the reasons behind the finding are unclear, the researchers speculate about hormonal and occupational exposures.
The cumulative dose with prolonged usage is what matters, researchers say.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.